Light and Light Ventures

Light & Light is a South Korean biotechnology company specializing in the development of advanced photodynamic therapy (PDT) for the treatment of various cancers. The company's core technology platform, L&L-PDT, combines proprietary photosensitizers with specialized laser delivery systems to selectively target and destroy malignant cells. Their lead candidate, L&L-101, is currently in Phase 1/2 clinical development for indications including hilar cholangiocarcinoma (bile duct cancer) and pancreatic cancer. Light & Light aims to provide minimally invasive therapeutic options that improve survival rates and quality of life for patients with difficult-to-treat solid tumors. The company was founded by clinical experts from the National Cancer Center of Korea and continues to collaborate on clinical research for unmet medical needs in oncology.